Literature DB >> 3514206

A mutational hot-spot within an intron of the mouse beta 2-microglobulin gene.

J R Parnes, K C Sizer, J G Seidman, V Stallings, R Hyman.   

Abstract

beta 2-Microglobulin is the smaller, relatively non-polymorphic chain of class I major histocompatibility complex proteins. We have previously described a mutant mouse cell line which had been selected for loss of the class I thymus leukemia (TL) antigen and had concomitantly lost surface expression of H-2k antigens. Expression of class I antigens on the cell surface was restored by fusion to an antigenically distinct mouse lymphoma line, and the defect in the mutant was shown to be the loss of a functional beta 2-microglobulin gene. We now describe three additional mutants with the same phenotype, all selected for loss of TL but after different types of mutagenesis. All of these mutants have genomic rearrangements resulting in the absence of a functional beta 2-microglobulin gene. These data provide strong evidence for the requirement of beta 2-microglobulin for cell surface expression of the heavy chain of class I major histocompatibility complex proteins. We further show that the defects in at least one beta 2-microglobulin gene in each mutant cell line map to the same small DNA segment within the first intron. The breakpoints of these mutations define a hypermutable site within the mouse beta 2-microglobulin gene.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3514206      PMCID: PMC1166701          DOI: 10.1002/j.1460-2075.1986.tb04183.x

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  33 in total

1.  Detection of specific sequences among DNA fragments separated by gel electrophoresis.

Authors:  E M Southern
Journal:  J Mol Biol       Date:  1975-11-05       Impact factor: 5.469

2.  RNA molecular weight determinations by gel electrophoresis under denaturing conditions, a critical reexamination.

Authors:  H Lehrach; D Diamond; J M Wozney; H Boedtker
Journal:  Biochemistry       Date:  1977-10-18       Impact factor: 3.162

3.  Screening lambdagt recombinant clones by hybridization to single plaques in situ.

Authors:  W D Benton; R W Davis
Journal:  Science       Date:  1977-04-08       Impact factor: 47.728

4.  Complementation patterns of Thy-1 variants and evidence that antigen loss variants "pre-exist" in the parental population.

Authors:  R Hyman; V Stallings
Journal:  J Natl Cancer Inst       Date:  1974-02       Impact factor: 13.506

5.  The T cell differentiation antigen Leu-2/T8 is homologous to immunoglobulin and T cell receptor variable regions.

Authors:  V P Sukhatme; K C Sizer; A C Vollmer; T Hunkapiller; J R Parnes
Journal:  Cell       Date:  1985-03       Impact factor: 41.582

6.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

7.  Molecular analysis of an EL4 cell line that expresses H-2Db but not H-2Kb or beta 2-microglobulin.

Authors:  T A Potter; R A Zeff; A M Schmitt-Verhulst; T V Rajan
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

8.  The beta2-microglobulin mRNA in human Daudi cells has a mutated initiation codon but is still inducible by interferon.

Authors:  F Rosa; H Berissi; J Weissenbach; L Maroteaux; M Fellous; M Revel
Journal:  EMBO J       Date:  1983       Impact factor: 11.598

9.  Beta 2-microglobulin induces intracellular transport of human class I transplantation antigen heavy chains in Xenopus laevis oocytes.

Authors:  L Severinsson; P A Peterson
Journal:  J Cell Biol       Date:  1984-07       Impact factor: 10.539

10.  Expression of H-2Db on the cell surface in the absence of detectable beta 2 microglobulin.

Authors:  T A Potter; C Boyer; A M Verhulst; P Golstein; T V Rajan
Journal:  J Exp Med       Date:  1984-07-01       Impact factor: 14.307

View more
  10 in total

Review 1.  Cancer vaccines: progress reveals new complexities.

Authors:  Zhiya Yu; Nicholas P Restifo
Journal:  J Clin Invest       Date:  2002-08       Impact factor: 14.808

2.  Gene deletions causing human genetic disease: mechanisms of mutagenesis and the role of the local DNA sequence environment.

Authors:  M Krawczak; D N Cooper
Journal:  Hum Genet       Date:  1991-03       Impact factor: 4.132

3.  Effect of proviral insertion on transcription of the murine B2mb gene.

Authors:  W N Frankel; T A Potter; T V Rajan
Journal:  J Virol       Date:  1989-06       Impact factor: 5.103

4.  Nuclear posttranscriptional processing of thymidine kinase mRNA at the onset of DNA synthesis.

Authors:  J M Gudas; G B Knight; A B Pardee
Journal:  Proc Natl Acad Sci U S A       Date:  1988-07       Impact factor: 11.205

Review 5.  Assumptions of the tumor 'escape' hypothesis.

Authors:  Nicholas P Restifo; Paul A Antony; Steven E Finkelstein; Wolfgang W Leitner; Deborah P Surman; Marc R Theoret; Christopher E Touloukian
Journal:  Semin Cancer Biol       Date:  2002-02       Impact factor: 15.707

6.  A mutant lymphoma cell line with a defective Thy-1 glycoprotein gene.

Authors:  G A Evans; R Hyman; K Lewis
Journal:  Immunogenetics       Date:  1987       Impact factor: 2.846

7.  Lack of HLA class I antigen expression by melanoma cells SK-MEL-33 caused by a reading frameshift in beta 2-microglobulin messenger RNA.

Authors:  Z Wang; Y Cao; A P Albino; R A Zeff; A Houghton; S Ferrone
Journal:  J Clin Invest       Date:  1993-02       Impact factor: 14.808

8.  Lack of HLA class I antigen expression by cultured melanoma cells FO-1 due to a defect in B2m gene expression.

Authors:  C M D'Urso; Z G Wang; Y Cao; R Tatake; R A Zeff; S Ferrone
Journal:  J Clin Invest       Date:  1991-01       Impact factor: 14.808

9.  Compilation of DNA strand exchange sites for non-homologous recombination in somatic cells.

Authors:  A K Konopka
Journal:  Nucleic Acids Res       Date:  1988-03-11       Impact factor: 16.971

10.  Rescue of Daudi cell HLA expression by transfection of the mouse beta 2-microglobulin gene.

Authors:  R H Seong; C A Clayberger; A M Krensky; J R Parnes
Journal:  J Exp Med       Date:  1988-02-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.